Acquired expression of p27 is a favorable prognostic indicator in patients with hepatocellular carcinoma

Clinical Cancer Research

Volumn 6, Issue 10, 2000, Pages 3966-3972

  Fiorentino, Michelangelo ^a   Altimari, Annalisa ^a   D'Errico, Antonia ^a   Cukor, Barry ^a   Barozzi, Chiara ^a   Loda, Massimo ^b   Grigioni, Walter Franco ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P27;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CORRELATION FUNCTION; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; WESTERN BLOTTING;

AGED; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CDC2-CDC28 KINASES; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER NEOPLASMS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; PRECIPITIN TESTS; PROGNOSIS; PROTEIN-SERINE-THREONINE KINASES; TIME FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 0033766176     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Cancer cell cycles
2. Cell cycle and cancer: Critical events at the G1 restriction point
3. Tumor surveillance via the ARF-p53 pathway
4. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinase CDK4 and CDK6
5. Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitors with homology to p16 INK4
6. Cloning of p27kip1, a cyclin dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals
7. A novel inhibitor of cyclin-cdk activity detected in transforming growth factor β-arrested epithelial cells
8. Assignment of the human p27Kip1 gene to 12p13 and its analysis in leukemias
9. Crystal structure of the p27kip1 cyclin-dependent kinase inhibitor bound to the cyclin -Cdk2 complex
10. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis and female sterility in p27kip1-deficient mice
11. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27kip
12. Mice lacking p27kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia and pituitary tumors
13. The murine gene p27kip1 is haploinsufficient for tumor suppression
14. p27Kip1: Chromosomal mapping to 12p12-12p13.1 and absence of mutation in human tumors
15. p27Kip1 mutation found in breast cancer
16. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27Kip1 in human malignancies
17. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27
18. The cell cycle inhibitor p27 is an independent prognostic marker in small (T(1a, b)) invasive breast carcinomas
19. Expression of cell cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients
20. Decreased levels of the cell cycle inhibitor p27Kip1 protein: Prognostic implication in primary breast cancer
21. Increase proteasome-dependent degradation of the cyclin-depend kinase inhibitor p27 in aggressive colorectal carcinoma
22. Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastasis
23. Localization and expression of p27Kip1 in multistage colorectal carcinogenesis
24. p27 Expression and gastric carcinoma
25. Distinct altered patterns of p27kip1 gene expression in benign prostatic hyperplasia and prostatic carcinoma
26. Loss of cyclin-dependent kinase inhibitor p27kip1 is a novel prognostic factor in localized human prostate adenocarcinoma
27. Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma
28. Role of p27Kip1 and cyclin-dependent kinase 2 in the proliferation of non-small cell lung cancer
29. Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer
30. Alteration of cell cycle-related genes in hepatocarcinogenesis
31. Protein expression of p53, p21waf1, and Rb as prognostic indicators in patients with surgically treated hepatocellular carcinoma
32. Cell cycle gene regulation in reversibly differentiated new human hepatoma cell lines
33. Involvement of p21 and p27 in the regulation of CDK activity and cell cycle progression in the regenerating liver
34. Expression and prognostic roles of the Gi-S modulators in hepatocellular carcinoma: P27 Independently predicts the recurrence
35. Assessment of the biological malignancy of hepatocellular carcinoma: Relationship to clinico-pathological factors and prognosis
36. Predictive factors for intrahepatic recurrence of hepatocellular carcinoma after partial hepatectomy
37. Hepatic resection for hepatocellular carcinoma
38. Ki-67 expression as a prognostic marker in patients with hepatocellular carcinoma
39. p53 Mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumor ablation
40. Influence of coexisting cirrhosis on long term prognosis after surgery in patients with hepatocellular carcinoma
41. Regulation of G(1) cyclin-dependent kinases in the liver: Role of nuclear localization and p27 sequestration
42. Overexpressed cyclin D3 contribute to retaining the growth inhibitor p27 in the cytoplasm of thyroid tumor cells
43. Silibinin decreases prostate-specific antigen with cell-growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: Implications for prostate cancer intervention
44. Indole-3-carbinol and tamoxifen cooperate to arrest the cell-cycle of MCF-7 human breast cancer cells